Search research articles
Contact Us
Filters
Showing results (121-130 of 287) with videos related to
Page
of 29
Sort By:
European Journal of Gastroenterology & Hepatology
|
March 7, 2019
Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades
Annick Moens, Bram Verstockt, Kathleen Machiels, et al.
Inflammatory Bowel Diseases
|
August 11, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center
Michiel Bronswijk, Annick Moens, Matthias Lenfant, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 10, 2016
Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease
Laurent Peyrin-Biroulet, Gert Van Assche, David Gómez-Ulloa, et al.
Journal of Crohn'S & Colitis
|
October 6, 2017
Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy
Marc Ferrante, Anthony de Buck van Overstraeten, Nikkie Schils, et al.
Journal of Crohn'S & Colitis
|
October 14, 2017
Biopsy-derived Intestinal Epithelial Cell Cultures for Pathway-based Stratification of Patients With Inflammatory Bowel Disease
Wiebe Vanhove, Kris Nys, Ingrid Arijs, et al.
Acta Gastro-Enterologica Belgica
|
March 9, 2007
Protein-losing enteropathy in Crohn's disease
Marc Ferrante, Freddy Penninckx, Gert De Hertogh, et al.
Journal of Crohn'S & Colitis
|
March 2, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study
Niels Vande Casteele, Filip Baert, Sumin Bian, et al.
Inflammatory Bowel Diseases
|
November 16, 2017
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time
Sumin Bian, Erwin Dreesen, Ho Tsun Tang, et al.
The American Journal of Gastroenterology
|
March 17, 2011
Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study
Christine Breynaert, Marc Ferrante, Herma Fidder, et al.
The AAPS Journal
|
December 20, 2018
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information
Iris Detrez, Ganel Schops, Jolien Lefrère, et al.
Page
of 29
Search research articles
Search
Showing results (121-130 of 287) with videos related to
Sort By:
Page
of 29
European Journal of Gastroenterology & Hepatology
|
March 7, 2019
Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades
Annick Moens, Bram Verstockt, Kathleen Machiels, et al.
Inflammatory Bowel Diseases
|
August 11, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center
Michiel Bronswijk, Annick Moens, Matthias Lenfant, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 10, 2016
Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease
Laurent Peyrin-Biroulet, Gert Van Assche, David Gómez-Ulloa, et al.
Journal of Crohn'S & Colitis
|
October 6, 2017
Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy
Marc Ferrante, Anthony de Buck van Overstraeten, Nikkie Schils, et al.
Journal of Crohn'S & Colitis
|
October 14, 2017
Biopsy-derived Intestinal Epithelial Cell Cultures for Pathway-based Stratification of Patients With Inflammatory Bowel Disease
Wiebe Vanhove, Kris Nys, Ingrid Arijs, et al.
Acta Gastro-Enterologica Belgica
|
March 9, 2007
Protein-losing enteropathy in Crohn's disease
Marc Ferrante, Freddy Penninckx, Gert De Hertogh, et al.
Journal of Crohn'S & Colitis
|
March 2, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study
Niels Vande Casteele, Filip Baert, Sumin Bian, et al.
Inflammatory Bowel Diseases
|
November 16, 2017
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time
Sumin Bian, Erwin Dreesen, Ho Tsun Tang, et al.
The American Journal of Gastroenterology
|
March 17, 2011
Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study
Christine Breynaert, Marc Ferrante, Herma Fidder, et al.
The AAPS Journal
|
December 20, 2018
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information
Iris Detrez, Ganel Schops, Jolien Lefrère, et al.
Page
of 29